• Some studies have noted that 3-5% of patients undergoing the Kasai procedure for EHBA are eventually diagnosed with nonsyndromic bile duct paucity or Alagille syndrome. (medscape.com)
  • As proof of principle, we applied DUCT to a mouse model for Alagille syndrome ( Jag1 Ndr/Ndr mice), characterized by intrahepatic bile duct paucity, that can spontaneously generate a biliary system in adulthood. (elifesciences.org)
  • Notch Signaling Regulates Formation of the Three-Dimensional Architecture of Intrahepatic Bile Ducts in Mice. (medscape.com)
  • Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. (medscape.com)
  • Surgical management for bile acid-induced pruritus includes biliary diversion and eventual orthotopic liver transplantation for those with refractory disease. (medscape.com)
  • DUCT identified increased central biliary branching and peripheral bile duct tortuosity as two compensatory processes occurring in distinct regions of Jag1 Ndr/Ndr liver, leading to full reconstitution of wild-type biliary volume and phenotypic recovery. (elifesciences.org)
  • Several studies have noted beneficial effects of either cholestyramine (12-15 g/d) or rifampin in the management of bile acid-induced pruritus found in patients with Alagille syndrome. (medscape.com)
  • The ileal bile acid transport (IBAT) inhibitor maralixibat (Livmarli) was approved in September 2021 for treatment of cholestatic pruritus in patients with Alagille syndrome aged 1 year and older. (medscape.com)
  • Worsening cholestasis and possible cefuroxime-induced liver injury following "successful" therapeutic endoscopic retrograde cholangiopancreatography for a distal common bile duct stone: a case report. (medscape.com)
  • Some studies have noted that 3-5% of patients undergoing the Kasai procedure for EHBA are eventually diagnosed with nonsyndromic bile duct paucity or Alagille syndrome. (medscape.com)
  • Alagille syndrome (OMIM #118450) is a multisystem disorder that is defined clinically by hepatic bile duct paucity and cholestasis, in association with cardiac, skeletal, and ophthalmologic manifestations, and characteristic facial features. (biomedcentral.com)
  • As proof of principle, we applied DUCT to a mouse model for Alagille syndrome ( Jag1 Ndr/Ndr mice), characterized by intrahepatic bile duct paucity, that can spontaneously generate a biliary system in adulthood. (elifesciences.org)
  • DUCT identified increased central biliary branching and peripheral bile duct tortuosity as two compensatory processes occurring in distinct regions of Jag1 Ndr/Ndr liver, leading to full reconstitution of wild-type biliary volume and phenotypic recovery. (elifesciences.org)
  • The hepatobiliary system comprises the liver, bile duct and gall bladder. (biomedcentral.com)
  • Liver biopsy specimens typically exhibit features suggestive of chronic cholestasis and paucity of interlobular bile ducts. (medscape.com)
  • typically, biopsy findings reveal interlobular bile ducts-to-portal ratio of less than 0.4 in 10 portal tracts. (medscape.com)
  • Less common considerations include inborn errors of bile acid metabolism (urine for bile acids) and progressive familial intrahepatic cholestasis . (medscape.com)
  • Surgical management for bile acid-induced pruritus includes biliary diversion and eventual orthotopic liver transplantation for those with refractory disease. (medscape.com)
  • Bile acid-induced pruritus is often recalcitrant to medical therapy and significantly affects quality of life. (medscape.com)
  • Prompt differential diagnosis is important because oral primary bile acid replacement may effectively reverse liver failure and restore liver functions. (biomedcentral.com)
  • New drug development based on gene-specific treatments, such as apical sodium-dependent bile acid transporter (ASBT) inhibitor, for BSEP defects are underway. (biomedcentral.com)
  • Serum bile acids are significantly elevated with increased amounts of cholic and chenodeoxycholic acids. (medscape.com)
  • Recent progress has elucidated the molecular mechanisms of bile metabolism, hepatocellular transport, bile ductular development, intestinal bile salt reabsorption, and the regulation of bile acids homeostasis. (biomedcentral.com)